New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?

Gunnar Birgegård; Carsten Bokemeyer

doi:10.1159/000088284

New guidelines on anaemia management in patients with cancer

Standard

New guidelines on anaemia management in patients with cancer : How do these affect clinical practice? / Birgegård, Gunnar; Bokemeyer, Carsten.

In: ONCOLOGY-BASEL, Vol. 69 Suppl 2, 2005, p. 17-21.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Birgegård, G & Bokemeyer, C 2005, 'New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?', ONCOLOGY-BASEL, vol. 69 Suppl 2, pp. 17-21. https://doi.org/10.1159/000088284

APA

Birgegård, G., & Bokemeyer, C. (2005). New guidelines on anaemia management in patients with cancer: How do these affect clinical practice? ONCOLOGY-BASEL, 69 Suppl 2, 17-21. https://doi.org/10.1159/000088284

Vancouver

Birgegård G, Bokemeyer C. New guidelines on anaemia management in patients with cancer: How do these affect clinical practice? ONCOLOGY-BASEL. 2005;69 Suppl 2:17-21. https://doi.org/10.1159/000088284

Bibtex

@article{1804a9707ef54122a4424d41491f0dcd,

title = "New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?",

abstract = "Anaemia is a condition that frequently occurs in patients with cancer, but a recent survey has cast doubt over whether it is being appropriately treated. These findings are disappointing considering the wealth of data showing the effectiveness of epoetin therapy in patients with cancer. Recently, evidence-based guidelines have been published that aim to provide physicians with the latest information required for optimal management of anaemia in patients with cancer. By increasing physician awareness of the appropriate therapy for anaemia management, more patients may receive the benefits of epoetin therapy.",

keywords = "Anemia, Hypochromic, Erythropoietin, Evidence-Based Medicine, Humans, Neoplasms, Physician's Practice Patterns, Practice Guidelines as Topic, Recombinant Proteins",

author = "Gunnar Birgeg{\aa}rd and Carsten Bokemeyer",

year = "2005",

doi = "10.1159/000088284",

language = "English",

volume = "69 Suppl 2",

pages = "17--21",

journal = "ONCOLOGY-BASEL",

issn = "0030-2414",

publisher = "S. Karger AG",

}

RIS

TY - JOUR

T1 - New guidelines on anaemia management in patients with cancer

T2 - How do these affect clinical practice?

AU - Birgegård, Gunnar

AU - Bokemeyer, Carsten

PY - 2005

Y1 - 2005

N2 - Anaemia is a condition that frequently occurs in patients with cancer, but a recent survey has cast doubt over whether it is being appropriately treated. These findings are disappointing considering the wealth of data showing the effectiveness of epoetin therapy in patients with cancer. Recently, evidence-based guidelines have been published that aim to provide physicians with the latest information required for optimal management of anaemia in patients with cancer. By increasing physician awareness of the appropriate therapy for anaemia management, more patients may receive the benefits of epoetin therapy.

AB - Anaemia is a condition that frequently occurs in patients with cancer, but a recent survey has cast doubt over whether it is being appropriately treated. These findings are disappointing considering the wealth of data showing the effectiveness of epoetin therapy in patients with cancer. Recently, evidence-based guidelines have been published that aim to provide physicians with the latest information required for optimal management of anaemia in patients with cancer. By increasing physician awareness of the appropriate therapy for anaemia management, more patients may receive the benefits of epoetin therapy.

KW - Anemia, Hypochromic

KW - Erythropoietin

KW - Evidence-Based Medicine

KW - Humans

KW - Neoplasms

KW - Physician's Practice Patterns

KW - Practice Guidelines as Topic

KW - Recombinant Proteins

U2 - 10.1159/000088284

DO - 10.1159/000088284

M3 - SCORING: Journal article

C2 - 16244506

VL - 69 Suppl 2

SP - 17

EP - 21

JO - ONCOLOGY-BASEL

JF - ONCOLOGY-BASEL

SN - 0030-2414

ER -